journal article·2015-10-27Open access

Crucial Role of Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-inflammatory Responses in Cells and Animals

Juan Ma, Rui Liu, Xiang Wang, Qian Liu, Yunan Chen, Russell P. Valle, Yi Y. Zuo, Tian Xia, Sijin Liu

ACS Nano· Volume 9· Issue 10

Abstract

Graphene oxide (GO) is increasingly used in biomedical applications because it possesses not only the unique properties of graphene including large surface area and flexibility but also hydrophilicity and dispersibility in aqueous solutions. However, there are conflicting results on its biocompatibility and biosafety partially due to large variations in physicochemical properties of GO, and the role of these properties including lateral size in the biological or toxicological effects of GO is still unclear. In this study, we focused on the role of lateral size by preparing a panel of GO samples with differential lateral sizes using the same starting material. We found that, in comparison to its smaller counterpart, larger GO showed a stronger adsorption onto the plasma membrane with less phagocytosis, which elicited more robust interaction with toll-like receptors and more potent activation of NF-κB pathways. By contrast, smaller GO sheets were more likely taken up by cells. As a result, larger GO promoted greater M1 polarization, associated with enhanced production of inflammatory cytokines and recruitment of immune cells. The in vitro results correlated well with local and systemic inflammatory responses after GO administration into the abdominal cavity, lung, or bloodstream through the tail vein. Together, our study delineated the size-dependent M1 induction of macrophages and pro-inflammatory responses of GO in vitro and in vivo. Our data also unearthed the detailed mechanism underlying these effects: a size-dependent interaction between GO and the plasma membrane.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China

Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, California 90095, United States

Department of Mechanical Engineering, University of Hawaii at Manoa, Honolulu, Hawaii 96822, United States

Funding

National Institute of Environmental Health Sciences · Chinese Academy of Sciences · Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (87)

Show source-provided references
1. 10.1002/adma.20120370010.1002/adma.201203700 ↗
2. 10.1021/ar300199e10.1021/ar300199e ↗
3. 10.1002/adhm.20130002310.1002/adhm.201300023 ↗
4. 10.4014/jmb.1412.1204510.4014/jmb.1412.12045 ↗
5. 10.2217/nnm.10.15810.2217/nnm.10.158 ↗
6. 10.2217/nnm.13.14010.2217/nnm.13.140 ↗
7. 10.1021/tx400385x10.1021/tx400385x ↗
8. 10.1021/nn402330b10.1021/nn402330b ↗
9. 10.1021/ar300199e10.1021/ar300199e ↗
10. 10.1016/j.toxlet.2010.11.01610.1016/j.toxlet.2010.11.016 ↗
11. 10.1016/j.biomaterials.2012.02.02110.1016/j.biomaterials.2012.02.021 ↗
12. 10.1021/nn403096s10.1021/nn403096s ↗
13. 10.1039/c3nr05431d10.1039/c3nr05431d ↗
14. 10.1016/j.colsurfb.2015.03.02210.1016/j.colsurfb.2015.03.022 ↗
15. 10.1021/ja803688x10.1021/ja803688x ↗
16. 10.1021/nn700375n10.1021/nn700375n ↗
17. 10.2147/IJN.S3739710.2147/IJN.S37397 ↗
18. 10.1016/j.cej.2011.12.07510.1016/j.cej.2011.12.075 ↗
19. 10.1038/nnano.2007.45110.1038/nnano.2007.451 ↗
20. 10.1021/ja201017510.1021/ja2010175 ↗
21. 10.1021/ja807934n10.1021/ja807934n ↗
22. 10.1039/c2cp42621h10.1039/c2cp42621h ↗
23. 10.1039/b613962k10.1039/b613962k ↗
24. 10.1016/j.epsl.2005.11.01410.1016/j.epsl.2005.11.014 ↗
25. 10.1016/j.ssc.2007.03.05210.1016/j.ssc.2007.03.052 ↗
26. 10.1016/j.vibspec.2014.07.00910.1016/j.vibspec.2014.07.009 ↗
27. 10.1016/j.carbon.2005.02.01810.1016/j.carbon.2005.02.018 ↗
28. 10.1016/j.biomaterials.2013.03.02410.1016/j.biomaterials.2013.03.024 ↗
29. 10.1186/1479-5876-12-13810.1186/1479-5876-12-138 ↗
30. 10.1002/smll.20130048110.1002/smll.201300481 ↗
31. 10.1084/jem.2007108710.1084/jem.20071087 ↗
32. 10.1016/j.biomaterials.2013.01.00110.1016/j.biomaterials.2013.01.001 ↗
33. 10.2147/IJN.S6659110.2147/IJN.S66591 ↗
34. 10.1021/acsnano.5b0129010.1021/acsnano.5b01290 ↗
35. 10.1038/nnano.2008.11110.1038/nnano.2008.111 ↗
36. 10.1038/nnano.2009.30510.1038/nnano.2009.305 ↗
37. 10.1038/nri97810.1038/nri978 ↗
38. 10.1038/ni.241910.1038/ni.2419 ↗
39. 10.1038/icb.1997.6810.1038/icb.1997.68 ↗
40. 10.1093/cvr/cvv14710.1093/cvr/cvv147 ↗
41. 10.1093/cvr/cvv15910.1093/cvr/cvv159 ↗
42. 10.1159/00036935010.1159/000369350 ↗
43. 10.1038/ki.2013.4610.1038/ki.2013.46 ↗
44. 10.1186/1743-8977-9-3210.1186/1743-8977-9-32 ↗
45. 10.1590/S0001-3765200900030001910.1590/S0001-37652009000300019 ↗
46. 10.1016/j.intimp.2015.01.01410.1016/j.intimp.2015.01.014 ↗
47. 10.1038/nature1203410.1038/nature12034 ↗
48. 10.1038/ni.193710.1038/ni.1937 ↗
49. 10.3389/fphar.2015.0005510.3389/fphar.2015.00055 ↗
50. 10.1002/jnr.2344810.1002/jnr.23448 ↗
51. 10.1016/j.bbadis.2014.12.01910.1016/j.bbadis.2014.12.019 ↗
52. 10.1038/nri173310.1038/nri1733 ↗
53. 10.1182/blood-2005-04-148510.1182/blood-2005-04-1485 ↗
54. 10.1021/nn203523610.1021/nn2035236 ↗
55. 10.1039/C4EN00134F10.1039/C4EN00134F ↗
56. 10.1021/nn305567s10.1021/nn305567s ↗
57. 10.1016/j.cell.2010.01.02210.1016/j.cell.2010.01.022 ↗
58. 10.1093/intimm/dxp01710.1093/intimm/dxp017 ↗
59. 10.1016/j.coi.2005.02.00710.1016/j.coi.2005.02.007 ↗
60. 10.1016/j.micinf.2004.08.01810.1016/j.micinf.2004.08.018 ↗
61. 10.1016/j.immuni.2009.09.01810.1016/j.immuni.2009.09.018 ↗
62. 10.1038/nature0783010.1038/nature07830 ↗
63. 10.1016/j.cell.2007.09.00910.1016/j.cell.2007.09.009 ↗
64. 10.1189/jlb.120674610.1189/jlb.1206746 ↗
65. 10.1016/j.biomaterials.2012.05.06410.1016/j.biomaterials.2012.05.064 ↗
66. 10.1016/j.immuni.2011.06.01410.1016/j.immuni.2011.06.014 ↗
67. 10.1016/S0898-6568(00)00149-210.1016/S0898-6568(00)00149-2 ↗
68. 10.3390/ijms14071315410.3390/ijms140713154 ↗
69. 10.1128/IAI.72.6.3147-3160.200410.1128/IAI.72.6.3147-3160.2004 ↗
70. 10.1016/j.ijpharm.2012.01.00310.1016/j.ijpharm.2012.01.003 ↗
71. 10.1002/adhm.20130059110.1002/adhm.201300591 ↗
72. 10.1016/j.cellsig.2013.08.00710.1016/j.cellsig.2013.08.007 ↗
73. 10.1038/nature0966310.1038/nature09663 ↗
74. 10.1038/cr.2011.2010.1038/cr.2011.20 ↗
75. 10.1083/jcb.20060503610.1083/jcb.200605036 ↗
76. 10.1021/nn507243w10.1021/nn507243w ↗
77. 10.1073/pnas.060099710310.1073/pnas.0600997103 ↗
78. 10.1371/journal.pone.001005110.1371/journal.pone.0010051 ↗
79. 10.1073/pnas.122227611010.1073/pnas.1222276110 ↗
80. 10.3389/fimmu.2014.0061410.3389/fimmu.2014.00614 ↗
81. 10.1172/JCI5964310.1172/JCI59643 ↗
82. 10.1038/nri307310.1038/nri3073 ↗
83. 10.1016/j.jim.2008.02.01610.1016/j.jim.2008.02.016 ↗
84. 10.1021/ac202264710.1021/ac2022647 ↗
85. 10.1021/am300253c10.1021/am300253c ↗
86. 10.1021/tx500422q10.1021/tx500422q ↗
87. 10.1158/0008-5472.CAN-09-154110.1158/0008-5472.CAN-09-1541 ↗